China’s health regulators have granted approvals for a string of brain-technology products this year, as domestic start-ups push to transform the treatment of conditions ranging from paraplegia to Alzheimer’s and depression. The approvals come as Beijing bids to lead the world in brain-computer interfaces – devices that allow patients to control digital devices using thought alone – offering generous policy support to help Chinese firms compete with overseas players such as Elon Musk’s...